primary antibodies against p53 (Affinity Biosciences)
Structured Review
Primary Antibodies Against P53, supplied by Affinity Biosciences, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primary+antibodies+against+p53/anti+p53/pm41616882-78-0-19
Average 86 stars, based on 1 article reviews
Images
Related Articles
other:Article Title: Fuzheng Shengbai Decoction Enhances Antitumor Immunity via YTHDC2-Dependent Stabilization of CLCA2 mRNA in Colorectal Cancer. Article Snippet: Ethnopharmacological relevance: Traditional Chinese medicine (TCM) has demonstrated multiple therapeutic advantages in colorectal cancer (CRC) management.. The herbal formula Fuzheng Shengbai Decoction (FZSB) has been widely used in clinical practice with well-documented therapeutic efficacy; nevertheless, the mechanisms underlying its anti-CRC effects remain largely unexplored.. Aim of the study: To evaluate the therapeutic efficacy of FZSB in colorectal cancer and its potential underlying mechanisms. Article Title: Artesunate attenuates pulmonary fibrosis by suppressing fibroblast senescence through inhibition of the STAT3/p53 signaling pathway. Article Snippet: Background: Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, and lethal lung disease with elusive pathogenesis.. Accumulating evidence implicates cellular senescence as a key mechanism in IPF.. Current therapies (pirfenidone/nintedanib) reduce acute exacerbation risk and delay lung function decline in mild-tomoderate IPF, but adverse effects often limit their use. |
